2023 Colorado Revised Statutes › Title 25 - PUBLIC HEALTH AND ENVIRONMENT (§§ 25-1-101 — 25-59-106) › DISEASE CONTROL (§§ 25-4-101 — 25-4-2504) › Article 4 - DISEASE CONTROL (§§ 25-4-101 — 25-4-2504) › Part 14 - HIV INFECTION AND ACQUIRED IMMUNE DEFICIENCY SYNDROME ASSISTANCE (§§ 25-4-1401 — 25-4-1405) › Section 25-4-1401 - Drug assistance program - program fund - HIV medications rebate fund - created - legislative declaration - no entitlement created

(1)
(a)
The general assembly recognizes that:
(I)
Medical science is making strides in treating individuals who have AIDS or HIV;
(II)
There are effective biomedical strategies to reduce new HIV infections;
(III)
Individuals at risk of HIV may also be at risk of other infectious diseases that can exacerbate the outcomes of an HIV infection;
(IV)
Individuals of lower income face barriers accessing biomedical interventions, particularly if they lack health insurance coverage or if their health insurance includes unaffordable premiums or cost-sharing requirements; and
(V)
Both the public health and quality of life would benefit from providing assistance with such costs and encouraging prompt and sustained treatment, eventually preventing further transmission of HIV, viral hepatitis, and sexually transmitted infections through prevention, cure, or viral suppression.
(b)
Therefore, the general assembly declares that the purpose of this section is to implement the drug assistance program for qualifying individuals of lower income who have medical or preventive needs concerning AIDS or HIV, viral hepatitis, or a sexually transmitted infection.
(c)
Nothing in this section shall be construed to establish any entitlement to services from the department of public health and environment.
(2)
(a)
Subject to available appropriations, the department of public health and environment is authorized to implement and administer a drug assistance program, referred to in this section as the "state program", to provide assistance with indicated screening, general medical, preventive, and pharmaceutical costs for eligible individuals.
(b)
The general assembly may annually appropriate moneys from the general fund to assist with indicated screening, general medical, preventive, and pharmaceutical costs for individuals participating in the state program.
(c)
The state program is also funded with federal funds available under the federal "Ryan White C.A.R.E. Act of 1990", as amended.
(d)
(I)
The HIV medications rebate fund, referred to in this subsection (2)(d) as the "fund", is created in the state treasury. The fund consists of any money received based on charges in excess of a federal price agreement and any additional money the general assembly appropriates to the fund. The general assembly shall continuously appropriate money in the fund to the department of public health and environment for use for the state program. Any money remaining in the fund at the end of a state fiscal year remains in the fund and shall not be credited or transferred to the general fund or any other fund.
(II)
The fund is not subject to the limit on uncommitted reserves in a cash fund established in section
24-75-402(3)
.
(e)
For activities of the state program funded by the drug assistance program fund that exceed the appropriation from the drug assistance program fund, if there are sufficient uncommitted moneys in the AIDS and HIV prevention fund, the program may use moneys appropriated for the implementation and administration of the state program from the AIDS and HIV prevention fund as authorized by section
25-4-1405
.
(3)
To be eligible to participate in the state program, an individual must:
(a)
Have a medical indication for treatment or prevention of HIV or AIDS, viral hepatitis, or another sexually transmitted infection;
(b)
Have a prescription from an authorized provider for a pharmaceutical product or combination of pharmaceutical products, as applicable, that are included on the drug formulary for the state program; and
(c)
Meet income eligibility requirements as determined by the department of public health and environment in consultation with the subcommittee of the advisory group on AIDS policy established in subsection (5) of this section.
(4)
Notwithstanding any other provision of this part 14 to the contrary, if a person meets the eligibility requirements set forth in subsection (3) of this section, he or she is eligible for programs and services that provide for the investigation, identification, testing, preventive care, or treatment of HIV infection or AIDS regardless of his or her race, religion, gender, ethnicity, national origin, or immigration status.
(5)
A subcommittee of an advisory group convened by the governor to make recommendations for HIV and AIDS policy in the state shall serve in an advisory role to the department of public health and environment in implementing the state program and shall provide advice and recommendations to the department of public health and environment concerning:
(a)
Which pharmaceutical products should be listed on the drug formulary for the state program;
(b)
Income and other eligibility requirements for the state program; and
(c)
The uses of funding for the state program pursuant to paragraphs (a) to (e) of subsection (2) of this section.
(6)
If at any time the department of public health and environment, in consultation with the subcommittee of the advisory group on HIV and AIDS policy established in subsection (5) of this section, determines that the drug assistance program is reaching the program's fiscal limitations, the department, in consultation with the subcommittee, shall implement a policy of giving preference to the highest-priority applicants of lower income, who otherwise meet the eligibility requirements in subsection (3) of this section, for enrollment into the program in the following rank order:
(a)
Individuals diagnosed with HIV or AIDS;
(b)
Individuals in need of treatment to prevent HIV infection;
(c)
Individuals diagnosed with other sexually transmitted infections that can be prevented or cured through currently available pharmaceutical treatments;
(d)
Individuals diagnosed with viral hepatitis;
(e)
Individuals with emerging care, treatment, or prevention needs concerning HIV, viral hepatitis, or other sexually transmitted infections.
(7)
(a)
The drug assistance program fund is created in the state treasury. The principal of the fund consists of tobacco litigation settlement moneys transferred by the state treasurer to the fund pursuant to section
24-75-1104.5
(1.7)(f), C.R.S. Subject to annual appropriation by the general assembly, the department of public health and environment may expend moneys from the fund for the state program. Any unexpended or unencumbered money remaining in the fund at the end of any fiscal year remains in the fund and shall not be credited or transferred to the general fund or any other fund.
(b)
The department of public health and environment and the advisory group shall determine how the moneys appropriated for the state program pursuant to this subsection (7) are to be used.
Amended by 2020 Ch. 282,§ 1, eff. 7/13/2020.
[Formerly 25-4-1411] Entire Part 14 amended by 2016 Ch. 230,§ 2, eff. 7/1/2016.
Amended by 2016 Ch. 153,§ 14, eff. 7/1/2016.
Amended by 2015 Ch. 165,§ 1, eff. 5/8/2015.
Amended by 2013 Ch. 74,§ 4, eff. 3/22/2013.
L. 2016: Entire part amended with relocations, (SB 16-146), ch. 230, p. 909, § 2, effective July 1; (7)(a) amended, (HB 16-1408), ch. 153, p. 466, § 14, effective July 1.
(1) This section is similar to former § 25-4-1411 as it existed prior to 2016.
(2) Amendments to § 25-4-1411(6)(a) by HB 16-1408 were harmonized with and relocated to subsection (7)(a) as it was amended by SB 16-146.
For the federal "Ryan White Comprehensive AIDS Resources Emergency Act of 1990", also referred to as the "Ryan White C.A.R.E. Act of 1990", see Pub.L. 101-381, codified at 42 U.S.C. § 300ff et seq.